Atrial Fibrillation in Acute Coronary Syndrome

about

Atrial Fibrillation in Acute Coronary Syndrome

Item

http://www.wikidata.org/entity/Q37495872

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Atrial Fibrillation in Acute Coronary Syndrome

@en

Atrial Fibrillation in Acute Coronary Syndrome.

@nl

type

Item

label

Atrial Fibrillation in Acute Coronary Syndrome

@en

Atrial Fibrillation in Acute Coronary Syndrome.

@nl

prefLabel

Atrial Fibrillation in Acute Coronary Syndrome

@en

Atrial Fibrillation in Acute Coronary Syndrome.

@nl

P1476

Atrial Fibrillation in Acute Coronary Syndrome

@en

P2093

Jason C Rubenstein

http://www.w3.org/2001/XMLSchema#string

Jennifer Wright

http://www.w3.org/2001/XMLSchema#string

Michael P Cinquegrani

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Validation of Clinical Classification Schemes for Predicting Stroke

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

P304

551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4022/JAFIB.551

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28496750

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

5153085

http://www.w3.org/2001/XMLSchema#string